ResearchMoz

Ankylosing Spondylitis (Bekhterevs Disease) Global Clinical Trials Review, H1, 2012

Publisher Name » GlobalData
Published Date » 2012-05-31
No. Of Pages » 155

GlobalData's clinical trial report, Ankylosing Spondylitis (Bekhterevs Disease) Global Clinical Trials Review, H1, 2012" provides data on the Ankylosing Spondylitis (Bekhterevs Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ankylosing Spondylitis (Bekhterevs Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ankylosing Spondylitis (Bekhterevs Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Ankylosing Spondylitis (Bekhterevs Disease) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ankylosing Spondylitis (Bekhterevs Disease) , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Ankylosing Spondylitis (Bekhterevs Disease) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Ankylosing Spondylitis (Bekhterevs Disease) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 36
Clinical Trial Overview of Abbott Laboratories 36
Merck & Co., Inc. 38
Clinical Trial Overview of Merck & Co., Inc. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
Teva Pharmaceutical Industries Limited 41
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
Boehringer Ingelheim GmbH 42
Clinical Trial Overview of Boehringer Ingelheim GmbH 42
Sanofi 43
Clinical Trial Overview of Sanofi 43
POZEN Inc. 44
Clinical Trial Overview of POZEN Inc. 44
Janssen Biotech, Inc. 45
Clinical Trial Overview of Janssen Biotech, Inc. 45
Schering-Plough Limited 46
Clinical Trial Overview of Schering-Plough Limited 46
Janssen Korea Ltd. 47
Clinical Trial Overview of Janssen Korea Ltd. 47
Array BioPharma Inc. 48
Clinical Trial Overview of Array BioPharma Inc. 48
Schering-Plough Corporation (Inactive) 49
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 49
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Mitsubishi Tanabe Pharma Corporation 51
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 51
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Celltrion, Inc. 53
Clinical Trial Overview of Celltrion, Inc. 53
Otsuka Pharmaceutical Co., Ltd. 54
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 54
AmpliPhi Biosciences Corporation 55
Clinical Trial Overview of AmpliPhi Biosciences Corporation 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
Charite- Universitatsmedizin Berlin 56
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 56
Sun Yat-sen University 57
Clinical Trial Overview of Sun Yat-sen University 57
University of Sao Paulo 58
Clinical Trial Overview of University of Sao Paulo 58
Federal University of Sao Paulo 59
Clinical Trial Overview of Federal University of Sao Paulo 59
Goteborg University 60
Clinical Trial Overview of Goteborg University 60
Imperial College London 61
Clinical Trial Overview of Imperial College London 61
University of Zurich 62
Clinical Trial Overview of University of Zurich 62
Academic Medical Centre 63
Clinical Trial Overview of Academic Medical Centre 63
Diakonhjemmet Hospital 64
Clinical Trial Overview of Diakonhjemmet Hospital 64
Swansea University 65
Clinical Trial Overview of Swansea University 65
Shandong University 66
Clinical Trial Overview of Shandong University 66
Instituto De Medicina Molecular 67
Clinical Trial Overview of Instituto De Medicina Molecular 67
Silkeborg Regional Hospital 68
Clinical Trial Overview of Silkeborg Regional Hospital 68
Asan Medical Center 69
Clinical Trial Overview of Asan Medical Center 69
Association de Recherche Clinique en Rhumatologie 70
Clinical Trial Overview of Association de Recherche Clinique en Rhumatologie 70
Far Eastern Memorial Hospital 71
Clinical Trial Overview of Far Eastern Memorial Hospital 71
Hvidovre University Hospital 72
Clinical Trial Overview of Hvidovre University Hospital 72
University Hospital, Tours 73
Clinical Trial Overview of University Hospital, Tours 73
Tel-Aviv Sourasky Medical Center 74
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 74
Chinese University of Hong Kong 75
Clinical Trial Overview of Chinese University of Hong Kong 75
Five Key Clinical Profiles 76

Appendix 152
Abbreviations 152
Definitions 152
Research Methodology 153
Secondary Research 153
About GlobalData 154
Contact Us 154
Disclaimer 154
Source 155

List of Tables


Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 36
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 38
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 39
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 40
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 41
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 42
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 43
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by POZEN Inc., 2012* 44
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012* 45
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Limited, 2012* 46
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Korea Ltd., 2012* 47
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2012* 48
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2012* 49
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 50
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2012* 51
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 52
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celltrion, Inc., 2012* 53
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 54
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AmpliPhi Biosciences Corporation, 2012* 55
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 56
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 57
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 58
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 59
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Goteborg University, 2012* 60
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 61
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 62
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 63
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Diakonhjemmet Hospital, 2012* 64
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Swansea University, 2012* 65
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2012* 66
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto De Medicina Molecular, 2012* 67
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Silkeborg Regional Hospital, 2012* 68
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 69
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Association de Recherche Clinique en Rhumatologie, 2012* 70
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2012* 71
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2012* 72
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2012* 73
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 74
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 75

List of Figures


Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Ankylosing Spondylitis (Bekhterevs Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
GlobalData Methodology 153

Upcoming Reports:

Orthopedics Market - Global Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2009 - 2018
By - Transparency Market Research
Orthopedics is the branch of medical science which deals with healing of bone and muscle related deformities. The global aging population, technological advancements in the field of orthopedics such as the invention of robotic minimally invasive procedures, and the rising healthcare related consumer expenditure are some of the growth drivers for the market. The future sustainability of the market will be ensured by the economic growth in the Asia Pacific and Latin American regions.  Joint replacement and reconstruction market held majority of the market share in 2011...
Self-Organizing Networks (SON) And Optimization Software Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
With growing number of mobile phone users every day and increasing network complexity, there is a rising demand for self organizing networks and optimization software to manage complex networks. As a result, future for SON and optimization software industry seems bright in the upcoming years. Implementation of 4G network resulted in network complexity, thus facilitating the need of effective technology to manage such complex networks. In anticipation of these issues, large operators have developed self organizing network technology to address these challenges.  Fourth...
Still Drinks Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Description Still drinks refers to drinks that include ready-to-drink fruit or non-fruit that typically contains juice content of lower than 25 percent, and water is also included in this sweetened flavor. Generally, in most countries consumers don’t tend to distinguish between juices, nectars, and the still drinks. It’s mostly the price that determines the consumer buying rather than the juice content. Of all the categories under the soft drinks, the still drinks market has shown continual growth with volumes advancing by almost close to 7% which is highest after...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...